Literature DB >> 16582881

Wiskott-Aldrich syndrome protein is involved in alphaIIb beta3-mediated cell adhesion.

Shigeru Tsuboi1, Shigeaki Nonoyama, Hans D Ochs.   

Abstract

The Wiskott-Aldrich syndrome (WAS) is an X-chromosome-linked immunodeficiency disorder. The most common symptom seen in WAS patients is bleeding. One of the main causes of bleeding is defective platelet aggregation. The causative gene of WAS encodes WAS protein (WASP). Here, we show that WASP binds to the calcium- and integrin-binding protein (CIB) in platelets. CIB was originally identified as a protein binding to the alphaIIb cytoplasmic tail of platelet integrin alphaIIb beta3, which has a primary role in platelet aggregation. We also show that the WASP-CIB complex is important in alphaIIb beta3-mediated cell adhesion, and that in patients mutant forms of WASP are expressed at reduced levels or show lower affinities for CIB than wild-type WASP. Our results indicate that impaired complex formation between mutant WASPs and CIB reduces alphaIIb beta3-mediated cell adhesion and causes defective platelet aggregation, resulting in bleeding.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16582881      PMCID: PMC1479562          DOI: 10.1038/sj.embor.7400665

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  18 in total

Review 1.  Bidirectional signaling between the cytoskeleton and integrins.

Authors:  S M Schoenwaelder; K Burridge
Journal:  Curr Opin Cell Biol       Date:  1999-04       Impact factor: 8.382

2.  Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype.

Authors:  Q Zhu; C Watanabe; T Liu; D Hollenbaugh; R M Blaese; S B Kanner; A Aruffo; H D Ochs
Journal:  Blood       Date:  1997-10-01       Impact factor: 22.113

Review 3.  Adhesive signaling in platelets.

Authors:  S J Shattil; M H Ginsberg; J S Brugge
Journal:  Curr Opin Cell Biol       Date:  1994-10       Impact factor: 8.382

Review 4.  Characterization of the Wiskott-Aldrich syndrome protein and its role in the disease.

Authors:  S Nonoyama; H D Ochs
Journal:  Curr Opin Immunol       Date:  1998-08       Impact factor: 7.486

5.  Identification of a novel calcium-binding protein that interacts with the integrin alphaIIb cytoplasmic domain.

Authors:  U P Naik; P M Patel; L V Parise
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

6.  Cloning and characterization of a cDNA encoding a highly conserved, putative calcium binding protein, identified by an anti-prolactin receptor antiserum.

Authors:  L C Murphy; L J Murphy; D Tsuyuki; M L Duckworth; R P Shiu
Journal:  J Biol Chem       Date:  1988-02-15       Impact factor: 5.157

7.  Isolation of a novel gene mutated in Wiskott-Aldrich syndrome.

Authors:  J M Derry; H D Ochs; U Francke
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

Review 8.  Platelet physiology and thrombosis.

Authors:  Robert K Andrews; Michael C Berndt
Journal:  Thromb Res       Date:  2004       Impact factor: 3.944

9.  Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 cases.

Authors:  C A Mullen; K D Anderson; R M Blaese
Journal:  Blood       Date:  1993-11-15       Impact factor: 22.113

10.  Clinical course of patients with WASP gene mutations.

Authors:  Kohsuke Imai; Tomohiro Morio; Yi Zhu; Yinzhu Jin; Sukeyuki Itoh; Michiko Kajiwara; Jun-Ichi Yata; Shuki Mizutani; Hans D Ochs; Shigeaki Nonoyama
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

View more
  22 in total

1.  Excitable waves at the margin of the contact area between a cell and a substrate.

Authors:  O Ali; C Albigès-Rizo; M R Block; B Fourcade
Journal:  Phys Biol       Date:  2009-07-01       Impact factor: 2.583

2.  Foamy virus vector-mediated gene correction of a mouse model of Wiskott-Aldrich syndrome.

Authors:  Toru Uchiyama; Marsilio Adriani; G Jayashree Jagadeesh; Adam Paine; Fabio Candotti
Journal:  Mol Ther       Date:  2012-01-03       Impact factor: 11.454

3.  Contra-regulation of calcium- and integrin-binding protein 1-induced cell migration on fibronectin by PAK1 and MAP kinase signaling.

Authors:  Meghna U Naik; Ulhas P Naik
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

4.  CIB1 deficiency results in impaired thrombosis: the potential role of CIB1 in outside-in signaling through integrin alpha IIb beta 3.

Authors:  M U Naik; A Nigam; P Manrai; P Millili; K Czymmek; M Sullivan; U P Naik
Journal:  J Thromb Haemost       Date:  2009-08-19       Impact factor: 5.824

5.  Calmodulin has the Potential to Function as a Ca-Dependent Adaptor Protein.

Authors:  Aaron P Yamniuk; Mario Rainaldi; Hans J Vogel
Journal:  Plant Signal Behav       Date:  2007-09

Review 6.  The thrombocytopenia of WAS: a familial form of ITP?

Authors:  Ted S Strom
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

7.  WASP plays a novel role in regulating platelet responses dependent on alphaIIbbeta3 integrin outside-in signalling.

Authors:  Anna Shcherbina; Jessica Cooley; Maxim I Lutskiy; Charaf Benarafa; Gary E Gilbert; Eileen Remold-O'Donnell
Journal:  Br J Haematol       Date:  2009-10-27       Impact factor: 6.998

8.  Sorting nexin 33 induces mammalian cell micronucleated phenotype and actin polymerization by interacting with Wiskott-Aldrich syndrome protein.

Authors:  Juan Zhang; Xiaofei Zhang; Yunqian Guo; Liangliang Xu; Duanqing Pei
Journal:  J Biol Chem       Date:  2009-06-01       Impact factor: 5.157

Review 9.  CIB1: a small protein with big ambitions.

Authors:  Tina M Leisner; Thomas C Freeman; Justin L Black; Leslie V Parise
Journal:  FASEB J       Date:  2016-04-26       Impact factor: 5.191

10.  FBP17 Mediates a Common Molecular Step in the Formation of Podosomes and Phagocytic Cups in Macrophages.

Authors:  Shigeru Tsuboi; Hidetoshi Takada; Toshiro Hara; Naoki Mochizuki; Tomihisa Funyu; Hisao Saitoh; Yuriko Terayama; Kanemitsu Yamaya; Chikara Ohyama; Shigeaki Nonoyama; Hans D Ochs
Journal:  J Biol Chem       Date:  2009-01-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.